• 靶点：
• p39

• 基因名称：
• CDK5R2

• 蛋白名称：
• Cyclin-dependent kinase 5 activator 2

• Human Gene Id：
• 8941

• Human Swiss Prot No：
• Q13319

• Mouse Swiss Prot No：
• O35926

• 免疫原：
• The antiserum was produced against synthesized peptide derived from human CDK5R2. AA range:81-130

• 特异性：
• p39 Polyclonal Antibody detects endogenous levels of p39 protein.

• 组成：
• Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

• 来源：
• Polyclonal, Rabbit,IgG

• 稀释：
• WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:20000.. IF 1:50-200

• 纯化工艺：
• The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

• 浓度：
• 1 mg/ml

• 储存：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• 其他名称：
• CDK5R2;NCK5AI;Cyclin-dependent kinase 5 activator 2;CDK5 activator 2;Cyclin-dependent kinase 5 regulatory subunit 2;p39;p39I

• 实测条带：
• 40kD

• 背景：
• The protein encoded by this gene is a neuron-specific activator of CDK5 kinase. It associates with CDK5 to form an active kinase. This protein and neuron-specific CDK5 activator CDK5R1/p39NCK5A both share limited similarity to cyclins, and thus may define a distinct family of cyclin-dependent kinase activating proteins. [provided by RefSeq, Jul 2008],

• 功能：
• function:Activator of CDK5/TPKII.,similarity:Belongs to the cyclin-dependent kinase 5 activator family.,subunit:Heterodimer of a catalytic subunit and a regulatory subunit.,tissue specificity:Brain and neuron specific.,

• 细胞定位：
• Cell membrane ; Lipid-anchor ; Cytoplasmic side .

• 组织表达：
• Brain and neuron specific.

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs